Shanghai Pharma buys U.S. Cardinal Health’s China business for $557 mln

The deal will also help Shanghai Pharma, China’s third largest drug distributor, become a leading importer of foreign medicine into the world’s second-largest drug market. By comparison, Shanghai Pharma, which is backed by the Shanghai government …
( read original story …)

Related Post